PathMaker Neurosystems Revenue and Competitors
Employee Data
- PathMaker Neurosystems has 3 Employees.
- PathMaker Neurosystems grew their employee count by -25% last year.
PathMaker Neurosystems's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and CEO | Reveal Email/Phone |
2 | VP Regulatory and Clinical Affairs | Reveal Email/Phone |
3 | Chief Technology Officer | Reveal Email/Phone |
4 | EVP & Chief IP Officer | Reveal Email/Phone |
5 | Research and Development Manager | Reveal Email/Phone |
PathMaker Neurosystems Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.5M | 17 | 0% | N/A | N/A |
#2 | N/A | 4 | 0% | N/A | N/A |
#3 | $7.5M | 114 | 7% | N/A | N/A |
#4 | $7.5M | 72 | 33% | N/A | N/A |
#5 | N/A | 17 | 55% | N/A | N/A |
#6 | $7.5M | 48 | -2% | N/A | N/A |
#7 | N/A | 32 | 33% | N/A | N/A |
#8 | N/A | 115 | 37% | N/A | N/A |
#9 | $1.7M | 9 | -18% | N/A | N/A |
#10 | N/A | 70 | -17% | N/A | N/A |
What Is PathMaker Neurosystems?
PathMaker Neurosystems is a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of serious neurological disorders such as Spasticity and ALS. Our first product, MyoRegulator, is the world's first non-invasive neuromodulation device for the treatment of muscle spasticity. With offices in Boston (US) and Paris (France), PathMaker is moving forward a trans-Atlantic strategy to rapidly bring to market entirely novel, breakthrough approaches to non-invasively treating disease using neuronal hyperexcitability suppression. At PathMaker, we are focused on enabling non-invasive treatment of patients with serious neurological disorders, without the need for drugs or surgery.
keywords:N/AN/A
Total Funding
3
Number of Employees
N/A
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0M | 3 | 0% | $4.6M |
#2 | $0.5M | 3 | N/A | N/A |
#3 | $0.2M | 3 | N/A | N/A |
#4 | $0.2M | 3 | N/A | N/A |
#5 | $0.1M | 3 | 0% | $4.7M |